Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Assessing the risk of transplant-related complications and individually tailoring the HSCT procedure in children and adolescents—is it possible?

Bone Marrow Transplantation volume 42, pages S90–S96 (2008)Cite this article

Abstract

Children surviving after haematopoietic SCT (HSCT) are a growing population that need to keep their health status under control. They may experience early and late complications that are related to transplant procedures and to treatments administered before HSCT. Monitoring transplant-related complications is mandatory, especially during the child's growth. The purpose of this report is to define preassessment in patients who are candidates for HSCT to identify any pretransplant, comorbid conditions and to individually tailor the HSCT procedure, whenever possible.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Mullighan CG, Bardy PG . New directions in the genomics of allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 127–144.

    Article  CAS  Google Scholar 

  2. Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M et al. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant. Int J Radiation Biol Phys 2005; 63: 1568–1575.

    Article  Google Scholar 

  3. Tichelli A, Gratwohl A, Egger T, Roth J, Prunte A, Niessen C et al. Cataract formation after bone marrow transplantation. Ann Intern Med 1993; 12: 1175–1180.

    Article  Google Scholar 

  4. Tichelli A, Duell T, Weiss M, Socié G, Ljungman P, Cohen A et al. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects. Bone Marrow Transplant 1996; 17: 1105–1111.

    CAS  PubMed  Google Scholar 

  5. Bylsma GW, Hall AJ, Szer J, West R . Atypical retinal microvasculopathy after bone marrow transplantation. Clin Experiment Ophthalmol 2001; 29: 225–229.

    Article  CAS  Google Scholar 

  6. Eames GM, Crosson J, Steinberger J, Steinbuch M, Krabill K, Bass J et al. Cardiovascular function in children following bone marrow transplant: a cross sectional study. Bone Marrow Transplant 1997; 19: 61–66.

    Article  CAS  Google Scholar 

  7. Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F et al. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Bone Marrow Transplantation 2007; 39: 667–675.

    Article  CAS  Google Scholar 

  8. Mitsui H, Kitayama H, Yamagami T, Osuga Y, Teshima H, Ueda T et al. Specific cardiomyopathy caused by high dose cyclophosphamide immediately after bone marrow transplantation. Rinsho Ketsueki 1989; 30: 387–391.

    CAS  PubMed  Google Scholar 

  9. Leiper AD . Non-endocrine late complications of bone marrow transplantation in childhood: part I. British J of Haematol 2002; 118: 3–22.

    Article  Google Scholar 

  10. Afessa B, Litzow MR, Tefferi A . Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 425–434.

    Article  CAS  Google Scholar 

  11. Dvorak CC, Steinbach WJ, Brown JM, Agarwal R . Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2005; 36: 621–629.

    Article  CAS  Google Scholar 

  12. Hovi L, Saarinen-Pihkala UM, Vettenranta K, Saxen H . Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant 2000; 26: 999–1004.

    Article  CAS  Google Scholar 

  13. Matsumoto M, Ishiguro H, Tomita Y, Inoue H, Yasuda Y, Shimizu T et al. Changes in thyroid function after bone marrow transplant in young patients. Pediatr Int 2004; 46: 291–295.

    Article  Google Scholar 

  14. Boulad F, Bromley M, Black P, Heller G, Sarafoglou K, Gillio A et al. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 1995; 15: 71–76.

    CAS  PubMed  Google Scholar 

  15. Sarafoglu K, Boulad F, Gillio A, Sklar C . Gonadal function after bone marrow transplantation for acute leukaemia during childhood. J Pediatr 1997; 130: 210–216.

    Article  Google Scholar 

  16. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ et al. Pregnancy following high-dose cyclophosphamide with or without high dose busulfan or total body irradiation and bone marrow transplantation. Blood 1996; 87: 3045–3052.

    CAS  PubMed  Google Scholar 

  17. Barker CC, Butzner JD, Anderson RA, Brant R, Sauve RS . Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2003; 32: 79–87.

    Article  CAS  Google Scholar 

  18. Reiss U, Cowan M, McMillan A, Horn B . Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients. J Pediatr Hematol Oncol 2002; 24: 746–750.

    Article  Google Scholar 

  19. Horn B, Reiss U, Matthay K, McMillan A, Cowan M . Veno-occlusive disease of the liver in children with solid tumors undergoing autologous hematopoietic progenitor cell transplantation: a high incidence in patients with neuroblastoma. Bone Marrow Transplant 2002; 29: 409–415.

    Article  CAS  Google Scholar 

  20. Lalazar G, Rund D, Shouval D . Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol 2007; 137: 81.

    Article  CAS  Google Scholar 

  21. Tomás JF, Pinilla I, García-Buey ML, García A, Figuera A, Gómez-García de Soria VGG et al. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients. Bone Marrow Transplant 2000; 26: 649–655.

    Article  Google Scholar 

  22. Matthes-Martin S, Lamche M, Ladenstein R, Emminger W, Felsberger C, Topf R et al. Organ toxicity and quality of life after allogeneic bone marrow transplantation in pediatric patients: a single centre retrospective analysis. Bone Marrow Transplant 1999; 23: 1049–1053.

    Article  CAS  Google Scholar 

  23. Socié G, Cahn Y, Carmelo J, Vernant JP, Jouet JP, Ifrah N et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Societé Francaise de Greffe de Moëlle (SFGM). British J of Haematol 1997; 97: 865–870.

    Article  Google Scholar 

  24. Torii Y, Hasegawas Y, Kubo T, Kodera Y, Minami S, Morishita Y et al. Osteonecrosis of the femoral head after allogeneic bone marrow transplantation. Clinical Orthopaed and Related Research 2001; 382: 124–132.

    Article  Google Scholar 

  25. Cesaro S, Brugiolo A, Faraci M, Uderzo C, Rondelli R, Favre C et al. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transplant 2003; 32: 925–931.

    Article  CAS  Google Scholar 

  26. Kist-van Holthe JE, Goedvolk CA, Brand R, van Weel MH, Bredius RG, van Oostayen JA et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 2002; 17: 1032–1037.

    Article  Google Scholar 

  27. Kist-van Holthe JE, van Zwet JML, Brand R, van Weel MH, Vossen JM, van der Heijden AJ . Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post BMT. Bone Marrow Transplantation 1998; 22: 559–564.

    Article  CAS  Google Scholar 

  28. Faraci M, Lanino E, Dini G, Fondelli MP, Morreale G, Dallorso S et al. Severe neurologic complications after hematopoietic stem cell transplantation in children. Neurology 2002; 59: 1895–1904.

    Article  CAS  Google Scholar 

  29. Thompson CB, Sanders JE, Flournoy N, Buckner CD, Thomas ED . The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia. Blood 1986; 67: 195–199.

    CAS  PubMed  Google Scholar 

  30. Gurney JG, Ness KK, Rosenthal J, Forman SJ, Bhatia S, Baker KS . Visual, auditory, sensory, and motor impairments in long-term survivors of haematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study. Cancer 2006; 106: 1402–1408.

    Article  Google Scholar 

  31. Belkacémi Y, Touboul E, Méric JB, Rat P, Warnet JM . Radiation-induced cataract: physiopathologic, radiobiologic and clinical aspects. Cancer Radiother 2001; 5: 397–412.

    Article  Google Scholar 

  32. www.survivorshipguidelines.org.

  33. Fahnehjelm KT, Törnquist AL, Olsson M, Winiarski J . Visual outcome and cataract development after allogeneic stem-cell transplantation in children. Acta Ophthalmol Scand 2007; 85: 724–733.

    Article  Google Scholar 

  34. Leiper AD . Non-endocrine late complications of bone marrow transplantation in childhood: part II. British J of Haematol 2002; 118: 23–43.

    Article  Google Scholar 

  35. van Kempen-Harteveld ML, van Weel-Sipman MH, Emmens C, Noordijk EM, van der Tweel I, Révész T et al. Eye shielding during total body irradiation for bone marrow transplantation in children transplanted for a hematological disorder: risks and benefits. Bone Marrow Transplant 2003; 31: 1151–1156.

    Article  CAS  Google Scholar 

  36. Benyunes MC, Sullivan KM, Deeg HJ, Mori M, Meyer W, Fisher L et al. Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation. Int J Radiat Oncol Biol Phys 1995; 32: 661–670.

    Article  CAS  Google Scholar 

  37. Hinkle AS, Proukou CB, Deshpande SS, Duffy SA, Kozlowski AM, French CA et al. Cardiotoxicity caused by chemotherapy. In: Wallace H, Green D (eds). Late Effects of Childhood Cancer. Arnold: London, 2004, chapter 4a, pp 85–100.

    Google Scholar 

  38. Erkus B, Demirtas S, Yarpuzlu AA, Can M, Genc Y, Karaca L . Early prediction of anthracycline induced cardiotoxicity. Acta Paediatr 2007; 96: 506–509.

    Article  Google Scholar 

  39. Rovelli A, Pezzini C, Silvestri D, Tana F, Galli MA, Uderzo C . Cardiac and respiratory function after bone marrow transplantation in children with leukemia. Bone Marrow Transplant 1995; 16: 571–576.

    CAS  PubMed  Google Scholar 

  40. Candoni A, Michelutti A, Simeone E, Damiani D, Baccarani M, Fanin R . Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins. Eur J Haematol 2006; 77: 293–299.

    Article  Google Scholar 

  41. Cerveri I, Zoia MC, Fulgoni P, Corsico A, Casali L, Tinelli C et al. Late pulmonary sequelae after childhood bone marrow transplantation. Thorax 1999; 54: 131–135.

    Article  CAS  Google Scholar 

  42. Ferry C, Gemayel G, Rocha V, Labopin M, Esperou H, Robin M et al. Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transplant 2007; 40: 219–224.

    Article  CAS  Google Scholar 

  43. Neyssa M, Sharis C, Tarbell N . Respiratory complications. In: Wallace H, Green D (eds). Late Effects of Childhood Cancer. Arnold: London, 2004, chapter 5, pp 114–122.

    Google Scholar 

  44. Sipsas NV, Kontoyiannis DP . Clinical issue regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with haematological malignancies. Clin Infect Dis 2006; 42: 1584–1591.

    Article  Google Scholar 

  45. Cesaro S, Cecchetto G, De Corti F, Dodero P, Giacchino M, Caviglia I et al. Results of a multicenter retrospective study of a combined medical and surgical approach to pulmonary aspergillosis in pediatric neutropenic patients. Pediatr Blood Cancer 2007; 49: 909–913.

    Article  Google Scholar 

  46. Al-Fiar FZ, Colwill R, Lipton JH, Fules G, Spaner D, Messner H . Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 1019–1022.

    Article  CAS  Google Scholar 

  47. Critchley HOD, Thomson AB, Wallace WHB . Ovarian and uterine function and reproductive potential. In: Wallace H, Green D (eds). Late Effects of Childhood Cancer. Arnold: London, 2004, chapter 8c, pp 225–238.

    Google Scholar 

  48. Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 1988; 6: 813–818.

    Article  CAS  Google Scholar 

  49. Wallace WHB, Thompson AB, Kelsey TW . Radiosensitivity of the human oocyte. Hum Reprod 2003; 18: 117–121.

    Article  CAS  Google Scholar 

  50. Spinelli S, Chiodi S, Bacigalupo A, Brasca A, Menada MV, Petti AR et al. Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: long-term follow-up of 79 females. Bone Marrow Transplant 1994; 14: 373–380.

    CAS  PubMed  Google Scholar 

  51. Socié G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A et al. A for the Late Effect Working Party of the European Group for Blood and Marrow Transplantation: nonmalignant late effects after allogeneic stem cell transplantation, Review Article. Blood 2003; 101: 3373–3385.

    Article  Google Scholar 

  52. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT). Bone Marrow Transplant 2006; 37: 249–261.

    Article  CAS  Google Scholar 

  53. Thomson AB, Hamish W, Wallace B, Sklar C . Testicular function. In: Wallace H, Green D (eds). Late Effects of Childhood Cancer. Arnold: London, 2004, chapter 8d, pp 240–256.

    Google Scholar 

  54. Bahadur G, Ozturk O, Muneer A, Wafa R, Ashraf A, Jaman N et al. Semen quality before and after gonadotoxic treatment. Hum Reprod 2005; 20: 774–781.

    Article  CAS  Google Scholar 

  55. Saito K, Suzuki K, Iwasaki A, Yumura Y, Kubota Y . Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer. Cancer 2005; 104: 521–524.

    Article  Google Scholar 

  56. Radich JP, Sanders JE, Buckner CD, Martin PJ, Petersen FB, Bensinger W et al. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens. J Clin Oncol 1993; 11: 304–313.

    Article  CAS  Google Scholar 

  57. Strasser SI, Myerson D, Spurgeon CL, Sullivan KM, Storer B, Schoch HG et al. Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up. Hepatology 1999; 29: 1893–1899.

    Article  CAS  Google Scholar 

  58. Lucarelli G, Clift RA, Galimberti M, Polchi P, Angelucci E, Baronciani D et al. Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood 1996; 87: 2082–2088.

    CAS  PubMed  Google Scholar 

  59. Hasegawa S, Horibe K, Kawabe T, Kato K, Kojima S, Matsuyama T et al. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors. Bone Marrow Transplant 1998; 22: 1191–1197.

    Article  CAS  Google Scholar 

  60. Wadleigh M, Richardson PG, Zahrieh D, Lee SJ, Cutler C, Ho V et al. Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation. Blood 2003; 102: 1578–1582.

    Article  CAS  Google Scholar 

  61. Meresse V, Hartmann O, Vassal G, Benhamou E, Valteau-Couanet D, Brugieres L et al. Risk factors for hepatic venoocclusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant 1992; 10: 135–141.

    CAS  PubMed  Google Scholar 

  62. Schulz AS, Classen CF, Mihatsch WA, Sigl-Kraetzig M, Wiesneth M, Debatin KM et al. HLA-haploidentical blood progenitor cell transplantation in osteopetrosis. Blood 2002; 99: 3458–3460.

    Article  CAS  Google Scholar 

  63. Ljungman P, Engelhard D, de la Cámara R, Einsele H, Locasciulli A, Martino R et al. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005; 35: 737–746.

    Article  CAS  Google Scholar 

  64. Faraci M, Calevo MG, Caruso S, Lanino E, Messina C, Favre C et al. Osteonecrosis after allogeneic stem cell transplantation in childhood. A case–control study in Italy. Haematologica 2006; 91: 1096–1099.

    PubMed  Google Scholar 

  65. Skinner R . Renal damage. In: Wallace H, Green D (eds). Late Effects of Childhood Cancer. Arnold: London, 2004, chapter 6a, pp 125–137.

    Google Scholar 

  66. Frisk P, Bratteby LE, Carlson K, Lönnerholm G . Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant 2002; 29: 129–136.

    Article  CAS  Google Scholar 

  67. Kist-van Holthe JE, Bresters D, Ahmed-Ousenkova YM, Goedvolk CA, Abbink FC, Wolterbeek R et al. Long-term renal function after hemopoietic stem cell transplantation in children. Bone Marrow Transplant 2005; 36: 605–610.

    Article  CAS  Google Scholar 

  68. Cool VA . Long-term neuropsychological risks in pediatric bone marrow transplant: what do we know? Bone Marrow Transplant 1996; 18 (Suppl 3): S45–S49.

    PubMed  Google Scholar 

  69. Coradini PP, Cigana L, Selistre SG, Rosito LS, Brunetto AL . Ototoxicity from cisplatin therapy in childhood cancer. J Pediatr Hematol Oncol 2007; 29: 355–360.

    Article  CAS  Google Scholar 

  70. Sonis AL . Craniofacial development,teeth and salivary gland. In: Wallace H and Green D (eds). Late Effects of Childhood Cancer. Arnold: London, 2004, chapter 7d, pp 176–185.

    Google Scholar 

  71. Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C et al. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation co-morbidities. Blood 2004; 104: 961–968.

    Article  CAS  Google Scholar 

  72. Alamo J, Shahjahan M, Lazarus HM, de Lima M, Giralt SA . Comorbidity indices in hematopoietic stem cell transplantation: a new report card. Bone Marrow Transplant 2005; 36: 473–474.

    Article  Google Scholar 

  73. http://ctep.cancer.gov/reporting/ctc.html.

  74. Stein J, Dini G, Yaniv I, Pediatric Diseases Working Party of the EBMT. The hope and the reality of reduced intensity transplants in children with malignant diseases. Bone Marrow Transplant 2005; 35 (Suppl 1): S39–S43.

    Article  Google Scholar 

  75. Del Toro G, Satwani P, Harrison L, Cheung YK, Brigid Bradley M, George D et al. A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients. Bone Marrow Transplant 2004; 33: 613–622.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by the Italian Ministry of Health, Programma di Ricerca Finalizzata ex articolo 12 D.L.gs 502/92 2005 ‘Assistenza Domiciliare in Bambini ed Adulti affetti da Patologie Emato-Oncologiche’.

Author information

Authors and Affiliations

  1. Department of Haematology and Oncology, Stem Cell Transplantation Unit, G Gaslini Children's Research Institute, Genova, Italy

    M Faraci & G Dini

Authors
  1. M Faraci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Dini
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the Paediatric Diseases Working Party

Corresponding author

Correspondence to M Faraci.

Additional information

Conflict of interest

The authors have declared no financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Faraci, M., Dini, G. & on behalf of the Paediatric Diseases Working Party. Assessing the risk of transplant-related complications and individually tailoring the HSCT procedure in children and adolescents—is it possible?. Bone Marrow Transplant 42 (Suppl 2), S90–S96 (2008). https://doi.org/10.1038/bmt.2008.292

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.292

Keywords

This article is cited by

Search

Advanced search

Quick links